Unassociated Document
 
United States
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

Form 15

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER
SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR
SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934.

Commission File No. 0-22710            

Interpharm Holdings, Inc.
(Exact name of registrant as specified in its charter)

75 Adams Avenue, Hauppauge, New York 11788     Tel. 631-952-0214
(Address, including zip code, and telephone number, including
area code, of registrant’s principal executive offices)

Common Stock, par value $.01 per share; Series A Preferred Stock, par value $.01 per share
(Title of each class of securities covered by this Form)

None
(Titles of all other classes of securities for which a duty
to file reports under Section 13(a) or 15(d) remains)

Please place an [x] in the box(es) to designate the appropriate rule
provision(s) relied upon to terminate or suspend the duty to file reports:

Rule 12g-4(a)(1)(i)
x
  
Rule 12h-3(b)(1)(i)
x
Rule 12g-4(a)(1)(ii)
o
  
Rule 12h-3(b)(1)(ii)
o
Rule 12g-4(a)(2)(i)
o
  
Rule 12h-3(b)(2)(i)
o
Rule 12g-4(a)(2)(ii)
o
  
Rule 12h-3(b)(2)(ii)
o
     
Rule 15d-6
o

Approximate number of holders of record as of the certification or notice date:       267       

Pursuant to the requirements of the Securities Exchange Act of 1934, Interpharm Holdings, Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.


  Interpharm Holdings, Inc.
   
Dated: 5/13/2008                         
By: Peter Giallorenzo, CFO